The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world healthcare resource utilization and costs among relapsed/refractory (R/R) mantle cell lymphoma (MCL) patients receiving ibrutinib or chemoimmunotherapy (CIT).
 
Nilanjan Ghosh
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Juno Therapeutics; Kite, a Gilead company; Seagen; Spectrum Pharmaceuticals; TG Therapeutics
Speakers' Bureau - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Janssen Oncology; Kite/Gilead; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Janssen (Inst); Juno Therapeutics (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
 
Bruno Emond
Research Funding - Janssen Scientific Affairs (Inst)
 
Marie-Hélène Lafeuille
Research Funding - Janssen Scientific Affairs (Inst)
 
Aurélie Côté-Sergent
Research Funding - Janssen Scientific Affairs (Inst)
 
Patrick Lefebvre
Research Funding - Janssen Scientific Affairs (Inst)
 
Qing Huang
Employment - Janssen Scientific Affairs